SEC Form 4 · accession 0001628908-18-000039
Evolent Health, Inc. · EVH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cheryl Scott
Director
Period of report
Jun 11, 2018
Accepted (ET)
Jun 12, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Jun 11, 2018 | S | 1,600 | $22.63 | D | 9,343 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.60-$22.675, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., and security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote.
- F2Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.